US$ 24.38
glp 1 and ibd Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, therapeutic potential Relevance of Glucagon-Like Peptide 1
Description
Eliud Sifonte, a diabetes and metabolism endocrinologist affiliated with NYU Langone Health, told Flow Space

Ask a question about this product We found other products you might like

Obesity (Silver Spring) 2012;20:505511

If not, talk to your doctor about samples or patient assistance programs offered by pharmaceutical companies

Sign up for my newsletter and get practical tips, honest insights, and science-backed strategies delivered to your inbox.
